|
UGGT1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.681600E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.620300E-02 |
| Normal-vs-Stage2 |
7.313500E-02 |
| Normal-vs-Stage3 |
9.304100E-02 |
| Normal-vs-Stage4 |
1.595420E-01 |
| Stage1-vs-Stage2 |
6.223200E-01 |
| Stage1-vs-Stage3 |
9.419600E-01 |
| Stage1-vs-Stage4 |
9.436800E-01 |
| Stage2-vs-Stage3 |
7.422400E-01 |
| Stage2-vs-Stage4 |
6.809200E-01 |
| Stage3-vs-Stage4 |
9.105600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.604200E-02 |
| Normal-vs-AfricanAmerican |
4.776700E-04 |
| Normal-vs-Asian |
8.176200E-01 |
| Caucasian-vs-AfricanAmerican |
5.481400E-03 |
| Caucasian-vs-Asian |
7.040200E-01 |
| AfricanAmerican-vs-Asian |
1.179410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.493800E-02 |
| Normal-vs-Female |
2.021400E-01 |
| Male-vs-Female |
1.750240E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.602400E-02 |
| Normal-vs-Age(41-60Yrs) |
7.692200E-02 |
| Normal-vs-Age(61-80Yrs) |
5.550400E-02 |
| Normal-vs-Age(81-100Yrs) |
3.919000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.435800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.299600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.755000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.845800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.381200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.729200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.592600E-01 |
| Normal-vs-Grade 2 |
2.174200E-02 |
| Normal-vs-Grade 3 |
5.122400E-02 |
| Normal-vs-Grade 4 |
6.356000E-01 |
| Grade 1-vs-Grade 2 |
2.373200E-01 |
| Grade 1-vs-Grade 3 |
3.172600E-01 |
| Grade 1-vs-Grade 4 |
7.695600E-01 |
| Grade 2-vs-Grade 3 |
8.123400E-01 |
| Grade 2-vs-Grade 4 |
1.481030E-01 |
| Grade 3-vs-Grade 4 |
1.867550E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.381700E-02 |
| Normal-vs-ccB subtype |
3.806600E-01 |
| ccA subtype-vs-ccB subtype |
2.181000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.525370E-01 |
| Normal-vs-N1 |
4.898000E-01 |
| N0-vs-N1 |
2.430000E-01 |
|
|
